nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ABCG2—Verapamil—migraine	0.135	0.341	CbGbCtD
Afatinib—ABCB1—Timolol—migraine	0.0798	0.201	CbGbCtD
Afatinib—ABCB1—Propranolol—migraine	0.0711	0.179	CbGbCtD
Afatinib—ABCB1—Amitriptyline—migraine	0.0615	0.155	CbGbCtD
Afatinib—ABCB1—Verapamil—migraine	0.0488	0.123	CbGbCtD
Afatinib—ERBB2—neck—migraine	0.00728	0.0511	CbGeAlD
Afatinib—PHKG2—brainstem—migraine	0.00619	0.0434	CbGeAlD
Afatinib—ERBB4—brainstem—migraine	0.00557	0.039	CbGeAlD
Afatinib—DYRK1A—brainstem—migraine	0.00536	0.0376	CbGeAlD
Afatinib—LCK—trigeminal ganglion—migraine	0.00459	0.0322	CbGeAlD
Afatinib—ERBB2—cardiovascular system—migraine	0.00454	0.0318	CbGeAlD
Afatinib—ERBB4—cardiovascular system—migraine	0.00454	0.0318	CbGeAlD
Afatinib—DYRK1A—cardiovascular system—migraine	0.00437	0.0307	CbGeAlD
Afatinib—EPHA6—head—migraine	0.00355	0.0249	CbGeAlD
Afatinib—PHKG2—head—migraine	0.00342	0.024	CbGeAlD
Afatinib—EPHA6—nervous system—migraine	0.00336	0.0236	CbGeAlD
Afatinib—HIPK4—brain—migraine	0.00325	0.0228	CbGeAlD
Afatinib—PHKG2—nervous system—migraine	0.00324	0.0227	CbGeAlD
Afatinib—EPHA6—central nervous system—migraine	0.00324	0.0227	CbGeAlD
Afatinib—PHKG2—central nervous system—migraine	0.00312	0.0219	CbGeAlD
Afatinib—ERBB4—head—migraine	0.00308	0.0216	CbGeAlD
Afatinib—ERBB2—head—migraine	0.00308	0.0216	CbGeAlD
Afatinib—PHKG2—cerebellum—migraine	0.00305	0.0214	CbGeAlD
Afatinib—DYRK1A—head—migraine	0.00296	0.0208	CbGeAlD
Afatinib—ERBB2—nervous system—migraine	0.00292	0.0204	CbGeAlD
Afatinib—ERBB4—nervous system—migraine	0.00292	0.0204	CbGeAlD
Afatinib—Stomatitis—Amitriptyline—migraine	0.00281	0.00848	CcSEcCtD
Afatinib—ERBB2—central nervous system—migraine	0.00281	0.0197	CbGeAlD
Afatinib—ERBB4—central nervous system—migraine	0.00281	0.0197	CbGeAlD
Afatinib—DYRK1A—nervous system—migraine	0.00281	0.0197	CbGeAlD
Afatinib—ERBB2—cerebellum—migraine	0.00274	0.0192	CbGeAlD
Afatinib—ERBB4—cerebellum—migraine	0.00274	0.0192	CbGeAlD
Afatinib—DYRK1A—central nervous system—migraine	0.0027	0.0189	CbGeAlD
Afatinib—Cystitis noninfective—Valproic Acid—migraine	0.00268	0.00807	CcSEcCtD
Afatinib—Cystitis—Valproic Acid—migraine	0.00265	0.00798	CcSEcCtD
Afatinib—DYRK1A—cerebellum—migraine	0.00264	0.0185	CbGeAlD
Afatinib—ABL1—trigeminal ganglion—migraine	0.00264	0.0185	CbGeAlD
Afatinib—EPHA6—brain—migraine	0.00257	0.018	CbGeAlD
Afatinib—Dry eye—Valproic Acid—migraine	0.00253	0.00763	CcSEcCtD
Afatinib—PHKG2—brain—migraine	0.00248	0.0174	CbGeAlD
Afatinib—Bladder pain—Valproic Acid—migraine	0.00248	0.00747	CcSEcCtD
Afatinib—Mouth ulceration—Valproic Acid—migraine	0.00248	0.00747	CcSEcCtD
Afatinib—Rhinorrhoea—Topiramate—migraine	0.00236	0.00711	CcSEcCtD
Afatinib—Infestation—Propranolol—migraine	0.00235	0.00709	CcSEcCtD
Afatinib—Infestation NOS—Propranolol—migraine	0.00235	0.00709	CcSEcCtD
Afatinib—ABL1—brainstem—migraine	0.00233	0.0164	CbGeAlD
Afatinib—EGFR—cerebellum—migraine	0.00233	0.0163	CbGeAlD
Afatinib—Alopecia—Amitriptyline—migraine	0.00229	0.0069	CcSEcCtD
Afatinib—Upper respiratory tract infection—Verapamil—migraine	0.00225	0.00679	CcSEcCtD
Afatinib—Dry eye—Timolol—migraine	0.00225	0.00679	CcSEcCtD
Afatinib—ERBB4—brain—migraine	0.00223	0.0156	CbGeAlD
Afatinib—ERBB2—brain—migraine	0.00223	0.0156	CbGeAlD
Afatinib—Cystitis noninfective—Gabapentin—migraine	0.00222	0.00669	CcSEcCtD
Afatinib—Dysgeusia—Amitriptyline—migraine	0.00221	0.00666	CcSEcCtD
Afatinib—Cystitis—Gabapentin—migraine	0.00219	0.00661	CcSEcCtD
Afatinib—DYRK1A—brain—migraine	0.00215	0.015	CbGeAlD
Afatinib—Dry eye—Gabapentin—migraine	0.0021	0.00633	CcSEcCtD
Afatinib—Bladder pain—Gabapentin—migraine	0.00205	0.00619	CcSEcCtD
Afatinib—Mouth ulceration—Gabapentin—migraine	0.00205	0.00619	CcSEcCtD
Afatinib—IRAK1—cerebellum—migraine	0.00205	0.0144	CbGeAlD
Afatinib—Sepsis—Gabapentin—migraine	0.00197	0.00594	CcSEcCtD
Afatinib—ABL1—cardiovascular system—migraine	0.0019	0.0133	CbGeAlD
Afatinib—EGFR—brain—migraine	0.00189	0.0132	CbGeAlD
Afatinib—Cystitis noninfective—Topiramate—migraine	0.00187	0.00563	CcSEcCtD
Afatinib—Alopecia—Propranolol—migraine	0.00186	0.00562	CcSEcCtD
Afatinib—Mental disorder—Propranolol—migraine	0.00185	0.00557	CcSEcCtD
Afatinib—Cystitis—Topiramate—migraine	0.00185	0.00556	CcSEcCtD
Afatinib—Dry skin—Valproic Acid—migraine	0.00182	0.0055	CcSEcCtD
Afatinib—Aspartate aminotransferase increased—Valproic Acid—migraine	0.00179	0.0054	CcSEcCtD
Afatinib—Dry eye—Topiramate—migraine	0.00176	0.00532	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Valproic Acid—migraine	0.00175	0.00529	CcSEcCtD
Afatinib—Renal impairment—Gabapentin—migraine	0.00173	0.00522	CcSEcCtD
Afatinib—Bladder pain—Topiramate—migraine	0.00173	0.00521	CcSEcCtD
Afatinib—Mouth ulceration—Topiramate—migraine	0.00173	0.00521	CcSEcCtD
Afatinib—Alopecia—Verapamil—migraine	0.00171	0.00517	CcSEcCtD
Afatinib—IRAK1—brain—migraine	0.00167	0.0117	CbGeAlD
Afatinib—Insomnia—Amitriptyline—migraine	0.00166	0.00502	CcSEcCtD
Afatinib—ABCG2—trigeminal ganglion—migraine	0.00166	0.0117	CbGeAlD
Afatinib—Muscle spasms—Verapamil—migraine	0.00162	0.0049	CcSEcCtD
Afatinib—Dyspepsia—Amitriptyline—migraine	0.00162	0.00489	CcSEcCtD
Afatinib—Cough—Propranolol—migraine	0.0016	0.00483	CcSEcCtD
Afatinib—Decreased appetite—Amitriptyline—migraine	0.0016	0.00483	CcSEcCtD
Afatinib—Fatigue—Amitriptyline—migraine	0.00159	0.00479	CcSEcCtD
Afatinib—Nasopharyngitis—Timolol—migraine	0.00158	0.00477	CcSEcCtD
Afatinib—Constipation—Amitriptyline—migraine	0.00157	0.00475	CcSEcCtD
Afatinib—Weight decreased—Valproic Acid—migraine	0.00156	0.00469	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.00155	0.00468	CcSEcCtD
Afatinib—Pneumonia—Valproic Acid—migraine	0.00154	0.00465	CcSEcCtD
Afatinib—Dehydration—Gabapentin—migraine	0.00153	0.00462	CcSEcCtD
Afatinib—Dry skin—Gabapentin—migraine	0.00151	0.00456	CcSEcCtD
Afatinib—Stomatitis—Valproic Acid—migraine	0.00149	0.00451	CcSEcCtD
Afatinib—Urinary tract infection—Valproic Acid—migraine	0.00149	0.00449	CcSEcCtD
Afatinib—Conjunctivitis—Valproic Acid—migraine	0.00149	0.00449	CcSEcCtD
Afatinib—Infection—Propranolol—migraine	0.00149	0.00449	CcSEcCtD
Afatinib—Nasopharyngitis—Gabapentin—migraine	0.00147	0.00445	CcSEcCtD
Afatinib—Nervous system disorder—Propranolol—migraine	0.00147	0.00443	CcSEcCtD
Afatinib—Skin disorder—Propranolol—migraine	0.00146	0.00439	CcSEcCtD
Afatinib—Body temperature increased—Amitriptyline—migraine	0.00146	0.00439	CcSEcCtD
Afatinib—Hepatobiliary disease—Valproic Acid—migraine	0.00145	0.00437	CcSEcCtD
Afatinib—Epistaxis—Valproic Acid—migraine	0.00145	0.00436	CcSEcCtD
Afatinib—Upper respiratory tract infection—Timolol—migraine	0.00142	0.00429	CcSEcCtD
Afatinib—Weight decreased—Timolol—migraine	0.00138	0.00417	CcSEcCtD
Afatinib—Infection—Verapamil—migraine	0.00137	0.00413	CcSEcCtD
Afatinib—Urinary tract disorder—Valproic Acid—migraine	0.00136	0.0041	CcSEcCtD
Afatinib—Insomnia—Propranolol—migraine	0.00136	0.00409	CcSEcCtD
Afatinib—Connective tissue disorder—Valproic Acid—migraine	0.00135	0.00408	CcSEcCtD
Afatinib—Urethral disorder—Valproic Acid—migraine	0.00135	0.00407	CcSEcCtD
Afatinib—Dyspnoea—Propranolol—migraine	0.00134	0.00403	CcSEcCtD
Afatinib—ABCB1—blood vessel—migraine	0.00133	0.0093	CbGeAlD
Afatinib—Conjunctivitis—Timolol—migraine	0.00133	0.004	CcSEcCtD
Afatinib—Upper respiratory tract infection—Gabapentin—migraine	0.00132	0.00399	CcSEcCtD
Afatinib—Asthenia—Amitriptyline—migraine	0.00132	0.00398	CcSEcCtD
Afatinib—Dyspepsia—Propranolol—migraine	0.00132	0.00398	CcSEcCtD
Afatinib—Decreased appetite—Propranolol—migraine	0.0013	0.00393	CcSEcCtD
Afatinib—Pruritus—Amitriptyline—migraine	0.0013	0.00393	CcSEcCtD
Afatinib—Gastrointestinal disorder—Propranolol—migraine	0.00129	0.0039	CcSEcCtD
Afatinib—Fatigue—Propranolol—migraine	0.00129	0.0039	CcSEcCtD
Afatinib—Dehydration—Topiramate—migraine	0.00129	0.00389	CcSEcCtD
Afatinib—Weight decreased—Gabapentin—migraine	0.00129	0.00389	CcSEcCtD
Afatinib—ABL1—head—migraine	0.00129	0.00904	CbGeAlD
Afatinib—Epistaxis—Timolol—migraine	0.00129	0.00388	CcSEcCtD
Afatinib—Eye disorder—Valproic Acid—migraine	0.00129	0.00388	CcSEcCtD
Afatinib—Constipation—Propranolol—migraine	0.00128	0.00386	CcSEcCtD
Afatinib—Pneumonia—Gabapentin—migraine	0.00128	0.00385	CcSEcCtD
Afatinib—Infestation—Gabapentin—migraine	0.00127	0.00383	CcSEcCtD
Afatinib—Infestation NOS—Gabapentin—migraine	0.00127	0.00383	CcSEcCtD
Afatinib—Hypokalaemia—Topiramate—migraine	0.00126	0.00381	CcSEcCtD
Afatinib—Diarrhoea—Amitriptyline—migraine	0.00126	0.0038	CcSEcCtD
Afatinib—Aspartate aminotransferase increased—Topiramate—migraine	0.00125	0.00377	CcSEcCtD
Afatinib—Renal failure—Gabapentin—migraine	0.00125	0.00377	CcSEcCtD
Afatinib—Insomnia—Verapamil—migraine	0.00125	0.00376	CcSEcCtD
Afatinib—Nasopharyngitis—Topiramate—migraine	0.00124	0.00374	CcSEcCtD
Afatinib—Mediastinal disorder—Valproic Acid—migraine	0.00124	0.00374	CcSEcCtD
Afatinib—Stomatitis—Gabapentin—migraine	0.00124	0.00373	CcSEcCtD
Afatinib—Urinary tract infection—Gabapentin—migraine	0.00123	0.00372	CcSEcCtD
Afatinib—Conjunctivitis—Gabapentin—migraine	0.00123	0.00372	CcSEcCtD
Afatinib—Dyspnoea—Verapamil—migraine	0.00123	0.00371	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Topiramate—migraine	0.00122	0.00369	CcSEcCtD
Afatinib—ABL1—nervous system—migraine	0.00122	0.00857	CbGeAlD
Afatinib—Dizziness—Amitriptyline—migraine	0.00122	0.00367	CcSEcCtD
Afatinib—Alopecia—Valproic Acid—migraine	0.00122	0.00367	CcSEcCtD
Afatinib—Dyspepsia—Verapamil—migraine	0.00121	0.00366	CcSEcCtD
Afatinib—Mental disorder—Valproic Acid—migraine	0.00121	0.00363	CcSEcCtD
Afatinib—Connective tissue disorder—Timolol—migraine	0.0012	0.00363	CcSEcCtD
Afatinib—Hepatobiliary disease—Gabapentin—migraine	0.0012	0.00362	CcSEcCtD
Afatinib—Epistaxis—Gabapentin—migraine	0.0012	0.00361	CcSEcCtD
Afatinib—Malnutrition—Valproic Acid—migraine	0.0012	0.00361	CcSEcCtD
Afatinib—Fatigue—Verapamil—migraine	0.00119	0.00358	CcSEcCtD
Afatinib—Body temperature increased—Propranolol—migraine	0.00118	0.00357	CcSEcCtD
Afatinib—Constipation—Verapamil—migraine	0.00118	0.00356	CcSEcCtD
Afatinib—ABL1—central nervous system—migraine	0.00118	0.00825	CbGeAlD
Afatinib—Dysgeusia—Valproic Acid—migraine	0.00117	0.00354	CcSEcCtD
Afatinib—Vomiting—Amitriptyline—migraine	0.00117	0.00353	CcSEcCtD
Afatinib—Rash—Amitriptyline—migraine	0.00116	0.0035	CcSEcCtD
Afatinib—Dermatitis—Amitriptyline—migraine	0.00116	0.0035	CcSEcCtD
Afatinib—Back pain—Valproic Acid—migraine	0.00116	0.00349	CcSEcCtD
Afatinib—Headache—Amitriptyline—migraine	0.00115	0.00348	CcSEcCtD
Afatinib—Muscle spasms—Valproic Acid—migraine	0.00115	0.00347	CcSEcCtD
Afatinib—ABL1—cerebellum—migraine	0.00115	0.00806	CbGeAlD
Afatinib—Eye disorder—Timolol—migraine	0.00114	0.00345	CcSEcCtD
Afatinib—Urinary tract disorder—Gabapentin—migraine	0.00113	0.0034	CcSEcCtD
Afatinib—Connective tissue disorder—Gabapentin—migraine	0.00112	0.00338	CcSEcCtD
Afatinib—Urethral disorder—Gabapentin—migraine	0.00112	0.00337	CcSEcCtD
Afatinib—Upper respiratory tract infection—Topiramate—migraine	0.00111	0.00336	CcSEcCtD
Afatinib—Mediastinal disorder—Timolol—migraine	0.0011	0.00333	CcSEcCtD
Afatinib—Nausea—Amitriptyline—migraine	0.00109	0.0033	CcSEcCtD
Afatinib—Weight decreased—Topiramate—migraine	0.00108	0.00327	CcSEcCtD
Afatinib—Alopecia—Timolol—migraine	0.00108	0.00326	CcSEcCtD
Afatinib—Asthenia—Propranolol—migraine	0.00108	0.00324	CcSEcCtD
Afatinib—Pneumonia—Topiramate—migraine	0.00108	0.00324	CcSEcCtD
Afatinib—Mental disorder—Timolol—migraine	0.00107	0.00324	CcSEcCtD
Afatinib—Infestation NOS—Topiramate—migraine	0.00107	0.00322	CcSEcCtD
Afatinib—Infestation—Topiramate—migraine	0.00107	0.00322	CcSEcCtD
Afatinib—Malnutrition—Timolol—migraine	0.00107	0.00322	CcSEcCtD
Afatinib—Eye disorder—Gabapentin—migraine	0.00107	0.00321	CcSEcCtD
Afatinib—Renal failure—Topiramate—migraine	0.00105	0.00317	CcSEcCtD
Afatinib—Cough—Valproic Acid—migraine	0.00105	0.00315	CcSEcCtD
Afatinib—Dysgeusia—Timolol—migraine	0.00104	0.00315	CcSEcCtD
Afatinib—Stomatitis—Topiramate—migraine	0.00104	0.00314	CcSEcCtD
Afatinib—Conjunctivitis—Topiramate—migraine	0.00104	0.00313	CcSEcCtD
Afatinib—Urinary tract infection—Topiramate—migraine	0.00104	0.00313	CcSEcCtD
Afatinib—Mediastinal disorder—Gabapentin—migraine	0.00103	0.0031	CcSEcCtD
Afatinib—Diarrhoea—Propranolol—migraine	0.00103	0.00309	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00101	0.00305	CcSEcCtD
Afatinib—Epistaxis—Topiramate—migraine	0.00101	0.00304	CcSEcCtD
Afatinib—Alopecia—Gabapentin—migraine	0.00101	0.00304	CcSEcCtD
Afatinib—Mental disorder—Gabapentin—migraine	0.000999	0.00301	CcSEcCtD
Afatinib—Malnutrition—Gabapentin—migraine	0.000993	0.00299	CcSEcCtD
Afatinib—Dizziness—Propranolol—migraine	0.000991	0.00299	CcSEcCtD
Afatinib—Asthenia—Verapamil—migraine	0.000989	0.00298	CcSEcCtD
Afatinib—Pruritus—Verapamil—migraine	0.000975	0.00294	CcSEcCtD
Afatinib—Dysgeusia—Gabapentin—migraine	0.000972	0.00293	CcSEcCtD
Afatinib—Infection—Valproic Acid—migraine	0.000971	0.00293	CcSEcCtD
Afatinib—Back pain—Gabapentin—migraine	0.00096	0.0029	CcSEcCtD
Afatinib—Nervous system disorder—Valproic Acid—migraine	0.000959	0.00289	CcSEcCtD
Afatinib—Muscle spasms—Gabapentin—migraine	0.000955	0.00288	CcSEcCtD
Afatinib—Vomiting—Propranolol—migraine	0.000953	0.00287	CcSEcCtD
Afatinib—Skin disorder—Valproic Acid—migraine	0.000949	0.00286	CcSEcCtD
Afatinib—Urinary tract disorder—Topiramate—migraine	0.000948	0.00286	CcSEcCtD
Afatinib—Rash—Propranolol—migraine	0.000945	0.00285	CcSEcCtD
Afatinib—Dermatitis—Propranolol—migraine	0.000944	0.00285	CcSEcCtD
Afatinib—Diarrhoea—Verapamil—migraine	0.000943	0.00284	CcSEcCtD
Afatinib—Connective tissue disorder—Topiramate—migraine	0.000943	0.00284	CcSEcCtD
Afatinib—Urethral disorder—Topiramate—migraine	0.000941	0.00284	CcSEcCtD
Afatinib—ABL1—brain—migraine	0.000934	0.00655	CbGeAlD
Afatinib—Cough—Timolol—migraine	0.00093	0.00281	CcSEcCtD
Afatinib—Dizziness—Verapamil—migraine	0.000912	0.00275	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000901	0.00272	CcSEcCtD
Afatinib—Eye disorder—Topiramate—migraine	0.000897	0.0027	CcSEcCtD
Afatinib—Nausea—Propranolol—migraine	0.00089	0.00268	CcSEcCtD
Afatinib—Insomnia—Valproic Acid—migraine	0.000884	0.00267	CcSEcCtD
Afatinib—Vomiting—Verapamil—migraine	0.000877	0.00264	CcSEcCtD
Afatinib—Dyspnoea—Valproic Acid—migraine	0.000871	0.00263	CcSEcCtD
Afatinib—Rash—Verapamil—migraine	0.000869	0.00262	CcSEcCtD
Afatinib—Dermatitis—Verapamil—migraine	0.000868	0.00262	CcSEcCtD
Afatinib—Cough—Gabapentin—migraine	0.000866	0.00261	CcSEcCtD
Afatinib—Mediastinal disorder—Topiramate—migraine	0.000865	0.00261	CcSEcCtD
Afatinib—Infection—Timolol—migraine	0.000864	0.00261	CcSEcCtD
Afatinib—Headache—Verapamil—migraine	0.000864	0.0026	CcSEcCtD
Afatinib—Dyspepsia—Valproic Acid—migraine	0.00086	0.00259	CcSEcCtD
Afatinib—Nervous system disorder—Timolol—migraine	0.000853	0.00257	CcSEcCtD
Afatinib—Decreased appetite—Valproic Acid—migraine	0.00085	0.00256	CcSEcCtD
Afatinib—Alopecia—Topiramate—migraine	0.000848	0.00256	CcSEcCtD
Afatinib—Skin disorder—Timolol—migraine	0.000845	0.00255	CcSEcCtD
Afatinib—Gastrointestinal disorder—Valproic Acid—migraine	0.000844	0.00254	CcSEcCtD
Afatinib—Fatigue—Valproic Acid—migraine	0.000843	0.00254	CcSEcCtD
Afatinib—Mental disorder—Topiramate—migraine	0.000841	0.00254	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000839	0.00253	CcSEcCtD
Afatinib—Constipation—Valproic Acid—migraine	0.000836	0.00252	CcSEcCtD
Afatinib—Malnutrition—Topiramate—migraine	0.000835	0.00252	CcSEcCtD
Afatinib—ABCB1—trigeminal ganglion—migraine	0.00082	0.00575	CbGeAlD
Afatinib—Nausea—Verapamil—migraine	0.000819	0.00247	CcSEcCtD
Afatinib—Dysgeusia—Topiramate—migraine	0.000818	0.00247	CcSEcCtD
Afatinib—Back pain—Topiramate—migraine	0.000808	0.00244	CcSEcCtD
Afatinib—Infection—Gabapentin—migraine	0.000805	0.00243	CcSEcCtD
Afatinib—Muscle spasms—Topiramate—migraine	0.000803	0.00242	CcSEcCtD
Afatinib—Nervous system disorder—Gabapentin—migraine	0.000795	0.0024	CcSEcCtD
Afatinib—Skin disorder—Gabapentin—migraine	0.000787	0.00237	CcSEcCtD
Afatinib—Insomnia—Timolol—migraine	0.000787	0.00237	CcSEcCtD
Afatinib—Dyspnoea—Timolol—migraine	0.000776	0.00234	CcSEcCtD
Afatinib—ABL1—Axon guidance—SCN1A—migraine	0.000773	0.00597	CbGpPWpGaD
Afatinib—Body temperature increased—Valproic Acid—migraine	0.000773	0.00233	CcSEcCtD
Afatinib—IRAK1—MAP kinase activation in TLR cascade—FOS—migraine	0.000771	0.00596	CbGpPWpGaD
Afatinib—Dyspepsia—Timolol—migraine	0.000766	0.00231	CcSEcCtD
Afatinib—ERBB2—Developmental Biology—MEF2D—migraine	0.000758	0.00586	CbGpPWpGaD
Afatinib—Decreased appetite—Timolol—migraine	0.000756	0.00228	CcSEcCtD
Afatinib—Gastrointestinal disorder—Timolol—migraine	0.000751	0.00227	CcSEcCtD
Afatinib—Fatigue—Timolol—migraine	0.00075	0.00226	CcSEcCtD
Afatinib—EGFR—SHP2 signaling—BDNF—migraine	0.000741	0.00573	CbGpPWpGaD
Afatinib—Insomnia—Gabapentin—migraine	0.000733	0.00221	CcSEcCtD
Afatinib—Cough—Topiramate—migraine	0.000729	0.0022	CcSEcCtD
Afatinib—ABCG2—cerebellum—migraine	0.000725	0.00508	CbGeAlD
Afatinib—Dyspnoea—Gabapentin—migraine	0.000722	0.00218	CcSEcCtD
Afatinib—LCK—SHP2 signaling—BDNF—migraine	0.000714	0.00552	CbGpPWpGaD
Afatinib—Dyspepsia—Gabapentin—migraine	0.000713	0.00215	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000706	0.00213	CcSEcCtD
Afatinib—Decreased appetite—Gabapentin—migraine	0.000704	0.00212	CcSEcCtD
Afatinib—Asthenia—Valproic Acid—migraine	0.000701	0.00211	CcSEcCtD
Afatinib—Gastrointestinal disorder—Gabapentin—migraine	0.0007	0.00211	CcSEcCtD
Afatinib—Fatigue—Gabapentin—migraine	0.000699	0.00211	CcSEcCtD
Afatinib—Constipation—Gabapentin—migraine	0.000693	0.00209	CcSEcCtD
Afatinib—Pruritus—Valproic Acid—migraine	0.000692	0.00209	CcSEcCtD
Afatinib—Body temperature increased—Timolol—migraine	0.000688	0.00207	CcSEcCtD
Afatinib—BLK—Apoptosis Modulation and Signaling—FOS—migraine	0.000685	0.00529	CbGpPWpGaD
Afatinib—Infection—Topiramate—migraine	0.000677	0.00204	CcSEcCtD
Afatinib—EGFR—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000669	0.00517	CbGpPWpGaD
Afatinib—Diarrhoea—Valproic Acid—migraine	0.000669	0.00202	CcSEcCtD
Afatinib—Nervous system disorder—Topiramate—migraine	0.000669	0.00202	CcSEcCtD
Afatinib—Skin disorder—Topiramate—migraine	0.000662	0.002	CcSEcCtD
Afatinib—EGFR—Axon guidance—SCN1A—migraine	0.00066	0.0051	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—SCN2A—migraine	0.000657	0.00508	CbGpPWpGaD
Afatinib—Dizziness—Valproic Acid—migraine	0.000646	0.00195	CcSEcCtD
Afatinib—Body temperature increased—Gabapentin—migraine	0.000641	0.00193	CcSEcCtD
Afatinib—LCK—IL-2 Signaling Pathway—FOS—migraine	0.000625	0.00483	CbGpPWpGaD
Afatinib—Asthenia—Timolol—migraine	0.000624	0.00188	CcSEcCtD
Afatinib—Vomiting—Valproic Acid—migraine	0.000621	0.00187	CcSEcCtD
Afatinib—Insomnia—Topiramate—migraine	0.000617	0.00186	CcSEcCtD
Afatinib—Rash—Valproic Acid—migraine	0.000616	0.00186	CcSEcCtD
Afatinib—Dermatitis—Valproic Acid—migraine	0.000616	0.00186	CcSEcCtD
Afatinib—Pruritus—Timolol—migraine	0.000616	0.00186	CcSEcCtD
Afatinib—Headache—Valproic Acid—migraine	0.000612	0.00185	CcSEcCtD
Afatinib—IRAK1—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	0.00061	0.00471	CbGpPWpGaD
Afatinib—Dyspnoea—Topiramate—migraine	0.000608	0.00183	CcSEcCtD
Afatinib—Dyspepsia—Topiramate—migraine	0.0006	0.00181	CcSEcCtD
Afatinib—Diarrhoea—Timolol—migraine	0.000595	0.0018	CcSEcCtD
Afatinib—Decreased appetite—Topiramate—migraine	0.000593	0.00179	CcSEcCtD
Afatinib—ABCB1—cardiovascular system—migraine	0.000592	0.00415	CbGeAlD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000591	0.00457	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000591	0.00457	CbGpPWpGaD
Afatinib—ABCG2—brain—migraine	0.000589	0.00413	CbGeAlD
Afatinib—Gastrointestinal disorder—Topiramate—migraine	0.000589	0.00177	CcSEcCtD
Afatinib—Fatigue—Topiramate—migraine	0.000588	0.00177	CcSEcCtD
Afatinib—Constipation—Topiramate—migraine	0.000583	0.00176	CcSEcCtD
Afatinib—Asthenia—Gabapentin—migraine	0.000581	0.00175	CcSEcCtD
Afatinib—Nausea—Valproic Acid—migraine	0.000581	0.00175	CcSEcCtD
Afatinib—Dizziness—Timolol—migraine	0.000575	0.00174	CcSEcCtD
Afatinib—Pruritus—Gabapentin—migraine	0.000573	0.00173	CcSEcCtD
Afatinib—ABL1—Regulation of Telomerase—ESR1—migraine	0.000573	0.00443	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—CACNA1A—migraine	0.000565	0.00437	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—SCN2A—migraine	0.000562	0.00434	CbGpPWpGaD
Afatinib—Diarrhoea—Gabapentin—migraine	0.000554	0.00167	CcSEcCtD
Afatinib—Vomiting—Timolol—migraine	0.000553	0.00167	CcSEcCtD
Afatinib—IRAK1—MyD88 cascade initiated on plasma membrane—FOS—migraine	0.000552	0.00427	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—SCN1A—migraine	0.000552	0.00426	CbGpPWpGaD
Afatinib—Rash—Timolol—migraine	0.000549	0.00165	CcSEcCtD
Afatinib—Dermatitis—Timolol—migraine	0.000548	0.00165	CcSEcCtD
Afatinib—IRAK1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	0.000547	0.00423	CbGpPWpGaD
Afatinib—Headache—Timolol—migraine	0.000545	0.00164	CcSEcCtD
Afatinib—Body temperature increased—Topiramate—migraine	0.000539	0.00163	CcSEcCtD
Afatinib—IRAK1—MyD88 dependent cascade initiated on endosome—FOS—migraine	0.000537	0.00415	CbGpPWpGaD
Afatinib—Dizziness—Gabapentin—migraine	0.000536	0.00162	CcSEcCtD
Afatinib—ERBB2—Signaling by ERBB4—ESR1—migraine	0.000532	0.00411	CbGpPWpGaD
Afatinib—BLK—PDGFR-beta signaling pathway—FOS—migraine	0.000531	0.00411	CbGpPWpGaD
Afatinib—PHKG2—Disease—LRP1—migraine	0.00053	0.00409	CbGpPWpGaD
Afatinib—ERBB4—Signaling by ERBB4—ESR1—migraine	0.000524	0.00405	CbGpPWpGaD
Afatinib—IRAK1—Apoptosis Modulation and Signaling—FOS—migraine	0.000523	0.00404	CbGpPWpGaD
Afatinib—IRAK1—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.000518	0.004	CbGpPWpGaD
Afatinib—Nausea—Timolol—migraine	0.000517	0.00156	CcSEcCtD
Afatinib—ABL1—Regulation of Telomerase—FOS—migraine	0.000516	0.00399	CbGpPWpGaD
Afatinib—Vomiting—Gabapentin—migraine	0.000515	0.00155	CcSEcCtD
Afatinib—LCK—IL2-mediated signaling events—FOS—migraine	0.000511	0.00395	CbGpPWpGaD
Afatinib—Rash—Gabapentin—migraine	0.000511	0.00154	CcSEcCtD
Afatinib—Dermatitis—Gabapentin—migraine	0.00051	0.00154	CcSEcCtD
Afatinib—IRAK1—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000509	0.00394	CbGpPWpGaD
Afatinib—Headache—Gabapentin—migraine	0.000508	0.00153	CcSEcCtD
Afatinib—ABCG2—Transmembrane transport of small molecules—TRPM8—migraine	0.000493	0.00381	CbGpPWpGaD
Afatinib—EGFR—Regulation of Telomerase—ESR1—migraine	0.00049	0.00378	CbGpPWpGaD
Afatinib—Asthenia—Topiramate—migraine	0.000489	0.00148	CcSEcCtD
Afatinib—IRAK1—MyD88-independent cascade—FOS—migraine	0.000489	0.00378	CbGpPWpGaD
Afatinib—Pruritus—Topiramate—migraine	0.000482	0.00145	CcSEcCtD
Afatinib—EGFR—Signaling by ERBB4—PGR—migraine	0.000482	0.00372	CbGpPWpGaD
Afatinib—Nausea—Gabapentin—migraine	0.000481	0.00145	CcSEcCtD
Afatinib—IRAK1—Toll-like Receptor Signaling Pathway—FOS—migraine	0.000477	0.00369	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—SCN1A—migraine	0.000471	0.00364	CbGpPWpGaD
Afatinib—LCK—IL12-mediated signaling events—FOS—migraine	0.00047	0.00363	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—SCN2A—migraine	0.000469	0.00362	CbGpPWpGaD
Afatinib—Diarrhoea—Topiramate—migraine	0.000466	0.00141	CcSEcCtD
Afatinib—LCK—Signaling by ERBB4—PGR—migraine	0.000464	0.00359	CbGpPWpGaD
Afatinib—EGFR—LPA receptor mediated events—FOS—migraine	0.000463	0.00358	CbGpPWpGaD
Afatinib—ERBB2—EGF/EGFR Signaling Pathway—FOS—migraine	0.000456	0.00352	CbGpPWpGaD
Afatinib—Dizziness—Topiramate—migraine	0.000451	0.00136	CcSEcCtD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000443	0.00343	CbGpPWpGaD
Afatinib—EGFR—Regulation of Telomerase—FOS—migraine	0.000441	0.00341	CbGpPWpGaD
Afatinib—IRAK1—Activated TLR4 signalling—FOS—migraine	0.00044	0.0034	CbGpPWpGaD
Afatinib—Vomiting—Topiramate—migraine	0.000433	0.00131	CcSEcCtD
Afatinib—Rash—Topiramate—migraine	0.00043	0.0013	CcSEcCtD
Afatinib—Dermatitis—Topiramate—migraine	0.000429	0.0013	CcSEcCtD
Afatinib—ABL1—Developmental Biology—MEF2D—migraine	0.000429	0.00332	CbGpPWpGaD
Afatinib—Headache—Topiramate—migraine	0.000427	0.00129	CcSEcCtD
Afatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000425	0.00328	CbGpPWpGaD
Afatinib—ABCG2—HIF-1-alpha transcription factor network—FOS—migraine	0.000422	0.00326	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—BDNF—migraine	0.00042	0.00325	CbGpPWpGaD
Afatinib—ABL1—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000419	0.00324	CbGpPWpGaD
Afatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000418	0.00323	CbGpPWpGaD
Afatinib—IRAK1—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	0.000413	0.00319	CbGpPWpGaD
Afatinib—Nausea—Topiramate—migraine	0.000405	0.00122	CcSEcCtD
Afatinib—ABCB1—head—migraine	0.000401	0.00281	CbGeAlD
Afatinib—EGFR—Developmental Biology—SCN2A—migraine	0.000401	0.0031	CbGpPWpGaD
Afatinib—ABCB1—nervous system—migraine	0.00038	0.00266	CbGeAlD
Afatinib—ABCG2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000374	0.00289	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000374	0.00289	CbGpPWpGaD
Afatinib—IRAK1—Regulation of toll-like receptor signaling pathway—FOS—migraine	0.000372	0.00288	CbGpPWpGaD
Afatinib—IRAK1—Toll-Like Receptors Cascades—FOS—migraine	0.000368	0.00285	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—MEF2D—migraine	0.000367	0.00283	CbGpPWpGaD
Afatinib—ABCB1—central nervous system—migraine	0.000366	0.00256	CbGeAlD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000365	0.00282	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000365	0.00282	CbGpPWpGaD
Afatinib—EGFR—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000358	0.00277	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000358	0.00277	CbGpPWpGaD
Afatinib—ABCB1—cerebellum—migraine	0.000358	0.00251	CbGeAlD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000348	0.00269	CbGpPWpGaD
Afatinib—PHKG2—Disease—CALCA—migraine	0.000341	0.00264	CbGpPWpGaD
Afatinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—migraine	0.000339	0.00262	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000334	0.00258	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—TGFBR2—migraine	0.000329	0.00254	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000324	0.00251	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor—TNF—migraine	0.000324	0.00251	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—HTR3A—migraine	0.000318	0.00246	CbGpPWpGaD
Afatinib—ABL1—PDGFR-beta signaling pathway—FOS—migraine	0.000317	0.00245	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—BDNF—migraine	0.000317	0.00245	CbGpPWpGaD
Afatinib—EGFR—ErbB1 downstream signaling—FOS—migraine	0.000312	0.00241	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—RAMP1—migraine	0.000309	0.00239	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CALCRL—migraine	0.000309	0.00239	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—RAMP1—migraine	0.000305	0.00235	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CALCRL—migraine	0.000305	0.00235	CbGpPWpGaD
Afatinib—ABL1—Integrated Breast Cancer Pathway—ESR1—migraine	0.000303	0.00234	CbGpPWpGaD
Afatinib—ABCB1—brain—migraine	0.00029	0.00204	CbGeAlD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000286	0.00221	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—FOS—migraine	0.000284	0.00219	CbGpPWpGaD
Afatinib—PHKG2—Disease—TGFBR2—migraine	0.000275	0.00213	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	0.000267	0.00206	CbGpPWpGaD
Afatinib—ERBB2—Disease—LRP1—migraine	0.000263	0.00203	CbGpPWpGaD
Afatinib—LCK—PDGFR-beta signaling pathway—FOS—migraine	0.000261	0.00202	CbGpPWpGaD
Afatinib—ERBB4—Disease—LRP1—migraine	0.000259	0.002	CbGpPWpGaD
Afatinib—EGFR—Integrated Breast Cancer Pathway—ESR1—migraine	0.000259	0.002	CbGpPWpGaD
Afatinib—ABL1—EGF/EGFR Signaling Pathway—FOS—migraine	0.000258	0.00199	CbGpPWpGaD
Afatinib—EGFR—Signaling by ERBB4—ESR1—migraine	0.000257	0.00199	CbGpPWpGaD
Afatinib—IRAK1—Toll-like Receptor Signaling Pathway—TNF—migraine	0.000256	0.00198	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CALCRL—migraine	0.000253	0.00196	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—RAMP1—migraine	0.000253	0.00196	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000251	0.00194	CbGpPWpGaD
Afatinib—LCK—Signaling by ERBB4—ESR1—migraine	0.000248	0.00192	CbGpPWpGaD
Afatinib—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	0.000228	0.00176	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR1D—migraine	0.000225	0.00174	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—RAMP1—migraine	0.000224	0.00173	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CALCRL—migraine	0.000224	0.00173	CbGpPWpGaD
Afatinib—PHKG2—Disease—MTHFR—migraine	0.000223	0.00173	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR1D—migraine	0.000221	0.00171	CbGpPWpGaD
Afatinib—EGFR—EGF/EGFR Signaling Pathway—FOS—migraine	0.00022	0.0017	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.00022	0.0017	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.000215	0.00166	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000214	0.00166	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—FOS—migraine	0.000214	0.00165	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR2B—migraine	0.000209	0.00161	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR2B—migraine	0.000206	0.00159	CbGpPWpGaD
Afatinib—EGFR—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000205	0.00159	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000202	0.00156	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000202	0.00156	CbGpPWpGaD
Afatinib—IRAK1—Regulation of toll-like receptor signaling pathway—TNF—migraine	0.0002	0.00155	CbGpPWpGaD
Afatinib—LCK—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000198	0.00153	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—MTHFR—migraine	0.000187	0.00145	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—LRP1—migraine	0.000184	0.00142	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR1D—migraine	0.000184	0.00142	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—LRP1—migraine	0.000181	0.0014	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	0.000172	0.00133	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR2B—migraine	0.000171	0.00132	CbGpPWpGaD
Afatinib—ERBB2—Disease—CALCA—migraine	0.000169	0.00131	CbGpPWpGaD
Afatinib—ERBB4—Disease—CALCA—migraine	0.000167	0.00129	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—FOS—migraine	0.000165	0.00127	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR1D—migraine	0.000162	0.00126	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—FOS—migraine	0.000162	0.00126	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—TNF—migraine	0.000153	0.00118	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR2B—migraine	0.000151	0.00117	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—RAMP1—migraine	0.00015	0.00116	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CALCRL—migraine	0.00015	0.00116	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000144	0.00111	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CALCRL—migraine	0.000144	0.00111	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—RAMP1—migraine	0.000144	0.00111	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NOTCH4—migraine	0.000141	0.00109	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NOTCH4—migraine	0.000139	0.00107	CbGpPWpGaD
Afatinib—ERBB2—Disease—TGFBR2—migraine	0.000136	0.00105	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR1B—migraine	0.000136	0.00105	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—TNF—migraine	0.000136	0.00105	CbGpPWpGaD
Afatinib—ERBB4—Disease—TGFBR2—migraine	0.000134	0.00104	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR1B—migraine	0.000134	0.00104	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—LRP1—migraine	0.000133	0.00103	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR1A—migraine	0.000131	0.00101	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR1A—migraine	0.000129	0.000998	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NPS—migraine	0.000129	0.000998	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PGR—migraine	0.000129	0.000998	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TAC1—migraine	0.000129	0.000998	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NPS—migraine	0.000127	0.000983	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PGR—migraine	0.000127	0.000983	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TAC1—migraine	0.000127	0.000983	CbGpPWpGaD
Afatinib—EGFR—Disease—LRP1—migraine	0.000127	0.000981	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR2C—migraine	0.000127	0.000978	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CACNA1A—migraine	0.000127	0.000978	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR2C—migraine	0.000125	0.000964	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—EDNRA—migraine	0.000123	0.000952	CbGpPWpGaD
Afatinib—LCK—Disease—LRP1—migraine	0.000122	0.000946	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.000121	0.000939	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—EDNRA—migraine	0.000121	0.000937	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NOTCH3—migraine	0.00012	0.000927	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—FOS—migraine	0.000119	0.000922	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CALCA—migraine	0.000119	0.000916	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NOTCH3—migraine	0.000118	0.000914	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CALCA—migraine	0.000117	0.000902	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—TNF—migraine	0.000115	0.000889	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR1B—migraine	0.000111	0.000861	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR7—migraine	0.000111	0.000857	CbGpPWpGaD
Afatinib—ERBB2—Disease—MTHFR—migraine	0.000111	0.000856	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR7—migraine	0.000109	0.000844	CbGpPWpGaD
Afatinib—ERBB4—Disease—MTHFR—migraine	0.000109	0.000843	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR1D—migraine	0.000109	0.00084	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000108	0.000836	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR1A—migraine	0.000107	0.000829	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—TNF—migraine	0.000106	0.000821	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—TAC1—migraine	0.000106	0.000816	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—NPS—migraine	0.000106	0.000816	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR1D—migraine	0.000105	0.000809	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.000104	0.000802	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR2C—migraine	0.000104	0.000801	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NOTCH4—migraine	0.000102	0.000789	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR2B—migraine	0.000101	0.000781	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—EDNRA—migraine	0.000101	0.000779	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—TNF—migraine	0.0001	0.000776	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR1B—migraine	9.84e-05	0.000761	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR2B—migraine	9.73e-05	0.000752	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CALCA—migraine	9.7e-05	0.00075	CbGpPWpGaD
Afatinib—ERBB2—Immune System—FOS—migraine	9.61e-05	0.000743	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TGFBR2—migraine	9.55e-05	0.000738	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR1A—migraine	9.48e-05	0.000732	CbGpPWpGaD
Afatinib—ERBB4—Immune System—FOS—migraine	9.46e-05	0.000731	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TGFBR2—migraine	9.41e-05	0.000727	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NPS—migraine	9.33e-05	0.000721	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PGR—migraine	9.33e-05	0.000721	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TAC1—migraine	9.33e-05	0.000721	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—FOS—migraine	9.33e-05	0.000721	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR2C—migraine	9.15e-05	0.000707	CbGpPWpGaD
Afatinib—BLK—Immune System—FOS—migraine	9.1e-05	0.000704	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR7—migraine	9.07e-05	0.000701	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—EDNRA—migraine	8.9e-05	0.000688	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—LRP1—migraine	8.89e-05	0.000687	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NOTCH3—migraine	8.68e-05	0.000671	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CALCA—migraine	8.57e-05	0.000662	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—LRP1—migraine	8.57e-05	0.000662	CbGpPWpGaD
Afatinib—EGFR—Disease—CALCA—migraine	8.18e-05	0.000632	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR7—migraine	8.02e-05	0.00062	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—FOS—migraine	7.97e-05	0.000616	CbGpPWpGaD
Afatinib—LCK—Disease—CALCA—migraine	7.89e-05	0.000609	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR2A—migraine	7.77e-05	0.0006	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—FOS—migraine	7.69e-05	0.000594	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR2A—migraine	7.65e-05	0.000591	CbGpPWpGaD
Afatinib—IRAK1—Immune System—FOS—migraine	6.95e-05	0.000537	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TGFBR2—migraine	6.9e-05	0.000534	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—ESR1—migraine	6.89e-05	0.000533	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CACNA1A—migraine	6.84e-05	0.000529	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NOTCH4—migraine	6.82e-05	0.000527	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—ESR1—migraine	6.79e-05	0.000525	CbGpPWpGaD
Afatinib—EGFR—Disease—TGFBR2—migraine	6.59e-05	0.000509	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR1B—migraine	6.58e-05	0.000509	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NOTCH4—migraine	6.58e-05	0.000508	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR2A—migraine	6.36e-05	0.000491	CbGpPWpGaD
Afatinib—LCK—Disease—TGFBR2—migraine	6.35e-05	0.000491	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR1B—migraine	6.34e-05	0.00049	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR1A—migraine	6.34e-05	0.00049	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PGR—migraine	6.24e-05	0.000482	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NPS—migraine	6.24e-05	0.000482	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TAC1—migraine	6.24e-05	0.000482	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR2C—migraine	6.12e-05	0.000473	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR1A—migraine	6.11e-05	0.000472	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NPS—migraine	6.01e-05	0.000465	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PGR—migraine	6.01e-05	0.000465	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TAC1—migraine	6.01e-05	0.000465	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—EDNRA—migraine	5.95e-05	0.00046	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR2C—migraine	5.9e-05	0.000456	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NOTCH3—migraine	5.8e-05	0.000448	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—EDNRA—migraine	5.74e-05	0.000443	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CALCA—migraine	5.73e-05	0.000443	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TNF—migraine	5.68e-05	0.000439	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR2A—migraine	5.61e-05	0.000434	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NOTCH3—migraine	5.59e-05	0.000432	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CALCA—migraine	5.52e-05	0.000427	CbGpPWpGaD
Afatinib—ABL1—Immune System—FOS—migraine	5.44e-05	0.00042	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR7—migraine	5.36e-05	0.000414	CbGpPWpGaD
Afatinib—EGFR—Disease—MTHFR—migraine	5.35e-05	0.000414	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	5.24e-05	0.000405	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR7—migraine	5.17e-05	0.000399	CbGpPWpGaD
Afatinib—LCK—Disease—MTHFR—migraine	5.16e-05	0.000399	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—ESR1—migraine	4.98e-05	0.000385	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TNF—migraine	4.85e-05	0.000375	CbGpPWpGaD
Afatinib—EGFR—Immune System—FOS—migraine	4.64e-05	0.000359	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TGFBR2—migraine	4.62e-05	0.000357	CbGpPWpGaD
Afatinib—LCK—Immune System—FOS—migraine	4.48e-05	0.000346	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TGFBR2—migraine	4.45e-05	0.000344	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—MTHFR—migraine	4.19e-05	0.000323	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR2A—migraine	3.75e-05	0.00029	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR2A—migraine	3.62e-05	0.00028	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ESR1—migraine	3.33e-05	0.000258	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ESR1—migraine	3.21e-05	0.000248	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—MTHFR—migraine	2.26e-05	0.000175	CbGpPWpGaD
